Gilead Sciences
GILD
#133
Rank
NZ$277.32 B
Marketcap
NZ$223.37
Share price
-1.18%
Change (1 day)
15.69%
Change (1 year)

Gilead Sciences (GILD) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : NZ$56.73 Billion

According to Gilead Sciences's latest financial reports the company's total liabilities are NZ$56.73 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Gilead Sciences - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$62.85 B-10.81%
2024-12-31NZ$70.48 B13.2%
2023-12-31NZ$62.26 B-5.79%
2022-12-31NZ$66.09 B-3.72%
2021-12-31NZ$68.64 B-1.31%
2020-12-31NZ$69.55 B20.18%
2019-12-31NZ$57.87 B-7.88%
2018-12-31NZ$62.82 B-10.37%
2017-12-31NZ$70.09 B29.09%
2016-12-31NZ$54.30 B13.99%
2015-12-31NZ$47.63 B98.06%
2014-12-31NZ$24.05 B82.43%
2013-12-31NZ$13.18 B-7.27%
2012-12-31NZ$14.21 B6.33%
2011-12-31NZ$13.37 B88.56%
2010-12-31NZ$7.09 B61.29%
2009-12-31NZ$4.39 B3.25%
2008-12-31NZ$4.25 B45.99%
2007-12-31NZ$2.91 B-7.31%
2006-12-31NZ$3.14 B191.26%
2005-12-31NZ$1.08 B170.44%
2004-12-31NZ$0.39 B-52.93%
2003-12-31NZ$0.84 B-38.03%
2002-12-31NZ$1.36 B66.14%
2001-12-31NZ$0.82 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
NZ$206.78 B 264.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$202.47 B 256.85%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$247.14 B 335.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$147.48 B 159.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$143.91 B 153.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$18.71 B-67.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$6.70 B-88.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$12.30 B-78.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$142.94 B 151.94%๐Ÿ‡บ๐Ÿ‡ธ USA